Literature DB >> 69529

Sleep patterns in mental retardation: Down's syndrome.

J Clausen, E A Sersen, A Lidsky.   

Abstract

EEG and eye movements during two consecutive nights were recorded in 21 "normal" and 21 Down's subjects of both sexes in the 14-24-year age range. Records of most Down's subjects were characterized by longer total sleep time, lack of waking alpha, frequent awakening and movement epochs and fewer spindle bursts. Significantly longer "awake" and stage 4 percentages, but less stage 2, were found in the Down's group. They also had longer REM latency, and lower eye movement density based on number of eye movements. Density based on integrated eye activity correlated positively with IQ in the Down's subjects. Spectrum analysis for EEG frequencies from 1 to 20 c/sec showed significantly greater power in the Down's group below 9 and above 12 c/sec, but no difference in the alpha range. The greater power at low frequencies was more pronounced in "awake", stage 1 and REM.

Entities:  

Mesh:

Year:  1977        PMID: 69529     DOI: 10.1016/0013-4694(77)90126-2

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  9 in total

1.  Parental report of sleep problems in children with autism.

Authors:  K A Schreck; J A Mulick
Journal:  J Autism Dev Disord       Date:  2000-04

2.  A Review of Sleep Disturbances among Infants and Children with Neurodevelopmental Disorders.

Authors:  Dana Kamara; Theodore P Beauchaine
Journal:  Rev J Autism Dev Disord       Date:  2019-12-26

Review 3.  About sleep's role in memory.

Authors:  Björn Rasch; Jan Born
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

4.  EEG and sleep in aged hospitalized patients with senile dementia: 24-h recordings.

Authors:  S R Allen; H B Stähelin; W O Seiler; R Spiegel
Journal:  Experientia       Date:  1983-03-15

5.  Long-term administration of butoctamide hydrogen succinate on nocturnal sleep of mentally retarded subjects: a polygraphic study versus placebo.

Authors:  G L Gigli; J C Grubar; P Bergonzi; M C Maschio
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

6.  High prevalence of sleep disorders and associated comorbidities in a community sample of children with Down syndrome.

Authors:  Claire A Hoffmire; Caroline I Magyar; Heidi V Connolly; I Diana Fernandez; Edwin van Wijngaarden
Journal:  J Clin Sleep Med       Date:  2014-04-15       Impact factor: 4.062

7.  Sleep patterns of Down's syndrome children: effects of butoctamide hydrogen succinate (BAHS) administration.

Authors:  J C Grubar; G L Gigli; R M Colognola; R Ferri; S A Musumeci; P Bergonzi
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

8.  Sleep, plasticity and the pathophysiology of neurodevelopmental disorders: the potential roles of protein synthesis and other cellular processes.

Authors:  Dante Picchioni; R Michelle Reith; Jeffrey L Nadel; Carolyn B Smith
Journal:  Brain Sci       Date:  2014-03-01

9.  Overexpression of Dyrk1A, a Down Syndrome Candidate, Decreases Excitability and Impairs Gamma Oscillations in the Prefrontal Cortex.

Authors:  Marcel Ruiz-Mejias; Maria Martinez de Lagran; Maurizio Mattia; Patricia Castano-Prat; Lorena Perez-Mendez; Laura Ciria-Suarez; Thomas Gener; Belen Sancristobal; Jordi García-Ojalvo; Agnès Gruart; José M Delgado-García; Maria V Sanchez-Vives; Mara Dierssen
Journal:  J Neurosci       Date:  2016-03-30       Impact factor: 6.167

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.